IMVT Crosses Above Average Analyst Target
August 26, 2020 at 09:06 AM EDT
In recent trading, shares of Immunovant Inc (IMVT) have crossed above the average analyst 12-month target price of $34.00, changing hands for $34.66/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..